American Head & Neck Society
Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.
Each year the AHNS Cancer Prevention Service awards Community Service Awards to individuals, departments, organizations or institutions in support of patient and community-oriented projects targeting head & neck cancer awareness and prevention. Drs. Vlad Sandulache and Diane Chen were recipients of this grant in 2019… There are approximately 3 million people in the U.S. living …
Phase 2 Trial of Neoadjuvant Chemotherapy and Transoral Endoscopic Surgery With Risk-Adapted Adjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck Weiss JM, Grilley-Olson JE, Deal AM, Zevallos JP, Chera BS, Paul J, Knowles MF, Usenko D, Weissler MC, Patel S, Hayes DN, Hackman T. From Clinical Trial. Cancer. July 2018; 124(14):2986-2992. Article Review by Aviram Mizrachi, MD Background / Hypothesis In this phase …
Volume 30 – April, 2020 The AHNS Journal Club reviews the leading head and neck cancer-related journals, sharing with AHNS members some of the most relevant and important manuscripts, and providing summaries and critiques of the work. The Journal Club members are: Samer Al-Khudari, MD; Daniel Brickman, MD; Nathan Hales, MD FACS; Jason Kass, MD …
The Head & Neck journal has a new special issue, COVID-19 versus Cancer: Impact on Head and Neck Oncology, to help head and neck oncologists all over the world in dealing with the pertinent issues surrounding the challenges they face during this pandemic. The issue is available for free full content download, globally using this link https://authorea.com/inst/20973 Dr. Ehab Hanna, …
Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer Sadeghi N, Khalife S, Mascarella MA, Ramanakumar AV, Richardson K, Joshi AS, Bouganim N, Taheri R, Fuson A, Siegel R. From Head and Neck, March 2020;42(3):417-425. Article Review by Joe Goodman, MD Background / Hypothesis According to the authors, a paradigm shift is underway leading to de-escalation trials for HPV-associated oropharynx cancer (OPC). Because of the excellent …
